270 related articles for article (PubMed ID: 21617141)
1. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141
[TBL] [Abstract][Full Text] [Related]
2. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
3. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy.
Jialal I; Major AM; Devaraj S
J Diabetes Complications; 2014; 28(6):755-61. PubMed ID: 25116192
[TBL] [Abstract][Full Text] [Related]
4. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
5. Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway.
Shao YX; Xu XX; Wang K; Qi XM; Wu YG
Drug Des Devel Ther; 2017; 11():3221-3233. PubMed ID: 29184392
[TBL] [Abstract][Full Text] [Related]
6. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
7. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
[TBL] [Abstract][Full Text] [Related]
9. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
11. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
[TBL] [Abstract][Full Text] [Related]
12. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
13. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
14. Macrophages directly mediate diabetic renal injury.
You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
[TBL] [Abstract][Full Text] [Related]
15. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice.
Dasu MR; Thangappan RK; Bourgette A; DiPietro LA; Isseroff R; Jialal I
Lab Invest; 2010 Nov; 90(11):1628-36. PubMed ID: 20733560
[TBL] [Abstract][Full Text] [Related]
16. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
17. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
Luan P; Zhuang J; Zou J; Li H; Shuai P; Xu X; Zhao Y; Kou W; Ji S; Peng A; Xu Y; Su Q; Jian W; Peng W
FASEB J; 2018 Feb; 32(2):1070-1084. PubMed ID: 29070585
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
19. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
20. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
